The Latest Breaking News from Eli Lilly

How should companies reframe ESG initiatives amid controversy? These executives offer their strategies.

These stocks make sense, given the relatively flat forecast for stocks over the next six months by Goldman strategists.

Amgen stock dipped Thursday though the company unveiled promising results for its experimental obesity treatment.

Half of Twitter's top 100 advertisers appear to no longer be advertising on the website. A new report states that these 50 advertisers have spent almost $2 billion on Twitter ads since 2020.

Until recently, Twitter’s blue checkmark logo was (for better or worse) a trusted mark of authenticity. But under the façade of democratizing the platform, Elon Musk allowed the blue checkmark to be purchased by anyone — with unsurprisingly chaotic results.

Furor over platform’s verified profiles may have done some good, but challenges still plague the site after a mass worker exodus

Posting on Twitter has changed since Elon Musk finalized his $44 billion takeover of the micro-blogging platform.

The past week has seen Twitter announce – and quickly retract – new rules for authenticating user profiles, notably a controversial proposal to offer “blue check” verification to anyone willing to pay $8 a month. New owner Elon Musk, who on Tuesday set November 29 as the scheme’s relaunch date,…

Fashion house Balenciaga has become the first brand to delete its Twitter account since the Musk acquisition.

A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis -- a new wave of scrutiny of the high cost of its insulin. Authentic-looking fake accounts proliferated last week after Twitter rolled out a paid verification service, the latest in a…

Washington (AFP) - A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis -- a new wave of scrutiny of the high cost of its insulin.